Drug Pipeline News

Latest News

Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive  | Image Credit: © JPC-PROD - © JPC-PROD - stock.adobe.com.
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive

December 5th 2023

Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.

Phase 2b study indicates Sildenafil Cream effective against female sexual arousal disorder | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
Phase 2b study indicates Sildenafil Cream effective against female sexual arousal disorder

November 2nd 2023

Ibrexafungerp tablets receive nationwide recall | Image Credit: © Veranika - © Veranika - stock.adobe.com.
Ibrexafungerp tablets receive nationwide recall

September 28th 2023

CDC recommends Pfizer’s maternal RSV vaccine to protect newborns | Image Credit: © JHVEPhoto - © JHVEPhoto - stock.adobe.com.
CDC recommends Pfizer’s maternal RSV vaccine to protect newborns

September 26th 2023

FDA accepts NDA for cefepime-taniborbactam for complicated UTIs | Image Credit: © wladimir1804 - © wladimir1804 - stock.adobe.com.
FDA accepts NDA for cefepime-taniborbactam for complicated UTIs

August 15th 2023

More News

© 2023 MJH Life Sciences

All rights reserved.